Filtros de búsqueda

Lista de obras de Joan B Geisbert

A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge

artículo científico publicado en 2012

A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys

scientific article published on 30 October 2019

A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

artículo científico publicado en 2015

A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

scientific article published in 2019

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

artículo científico publicado en 2019

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

artículo científico publicado en 2011

A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment

artículo científico publicado en 2010

A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge

scientific article published on 12 February 2014

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

artículo científico publicado en 2003

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys

artículo científico publicado en 2019

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone

artículo científico

Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection

artículo científico publicado en 2016

Antigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed by Baculovirus Recombinants

artículo científico publicado el 8 de diciembre de 1997

Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo

artículo científico publicado en 2016

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

artículo científico publicado en 2019

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

artículo científico publicado en 2011

Cellular immune response to Marburg virus infection in cynomolgus macaques

artículo científico publicado en 2008

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

artículo científico publicado en 2003

Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model

artículo científico publicado en 2015

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

artículo científico publicado en 2003

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys

artículo científico publicado en 2020

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

artículo científico publicado en 2006

Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques

artículo científico publicado en 2004

Development of Prototype Filovirus Recombinant Antigen Immunoassays

artículo científico publicado en 2015

Development of a new vaccine for the prevention of Lassa fever

artículo científico publicado en 2005

Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection

artículo científico publicado en 2010

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates

artículo científico publicado en 2014

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates

artículo científico publicado en 2007

Effective post-exposure treatment of Ebola infection

artículo científico publicado en 2007

Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates

scholarly article by Pavlo Gilchuk et al published 22 November 2018 in Journal of Infectious Diseases

Establishment of an African green monkey model for COVID-19

artículo científico publicado en 2020

Establishment of an African green monkey model for COVID-19 and protection against re-infection

artículo científico publicado en 2020

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

artículo científico publicado en 1999

Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections

artículo científico publicado en 2002

Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection

artículo científico publicado en 2016

Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies

artículo científico publicado en 1999

Framework for leadership and training of Biosafety Level 4 laboratory workers

artículo científico publicado en 2008

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

artículo científico publicado en 2017

Immune correlates of postexposure vaccine protection against Marburg virus

artículo científico publicado en 2020

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

artículo científico publicado en 2006

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

artículo científico publicado en 2007

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses

artículo científico publicado en 2001

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.

artículo científico

Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever

artículo científico publicado en 2012

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

artículo científico publicado en 2020

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

artículo científico publicado en 2020

Lassa fever in post-conflict sierra leone

artículo científico publicado en 2014

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

artículo científico publicado en 2015

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

artículo científico publicado en 2005

Lymphocyte death in a mouse model of Ebola virus infection

artículo científico publicado en 2007

Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.

artículo científico publicado en 2007

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.

artículo científico publicado en 2014

Marburg virus vaccines: comparing classical and new approaches

artículo científico publicado en 2001

Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.

artículo científico publicado en 2015

Monoclonal antibody therapy for Junin virus infection

artículo científico publicado en 2016

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

artículo científico publicado en 2016

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak

artículo científico publicado en 2015

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

artículo científico publicado en 2007

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus

artículo científico publicado en 2016

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates

artículo científico publicado en 2016

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

artículo científico publicado en 1996

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

artículo científico publicado en 2003

Pathogenesis of Lassa fever in cynomolgus macaques

artículo científico publicado en 2011

Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques

artículo científico publicado en 2011

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy

artículo científico publicado en 2016

Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus

artículo científico publicado en 2007

Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells

artículo científico publicado el 1 de agosto de 1997

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

scholarly article by Courtney Woolsey et al published 22 November 2018 in Journal of Infectious Diseases

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

artículo científico publicado en 2006

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference

artículo científico publicado en 2006

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

artículo científico publicado en 2010

Postexposure treatment of Marburg virus infection

artículo científico publicado en 2010

Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers

artículo científico publicado en 2009

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment

artículo científico publicado en 2020

Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA.

artículo científico publicado en 2013

Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates

artículo científico publicado en 2007

Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death

artículo científico publicado en 2020

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

artículo científico publicado en 2011

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever

artículo científico publicado en 2007

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates

artículo científico publicado en 2012

Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates

artículo científico publicado en 2008

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA

artículo científico publicado en 2016

Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity

artículo científico publicado en 2019

Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms

scholarly article by Kelly L Warfield et al published 22 November 2018 in Journal of Infectious Diseases

Single Dose Trivalent Vesiculovax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge

artículo científico publicado en 2017

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus

artículo científico publicado en 2011

Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

artículo científico publicado en 2015

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

artículo científico publicado en 2009

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus

artículo científico publicado en 2016

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

artículo científico publicado en 2015

Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.

artículo científico publicado en 2017

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody

artículo científico publicado en 2014

Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation

artículo científico publicado en 2011

Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus

artículo científico publicado en 2014

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis

artículo científico publicado en 2017

Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory

artículo científico publicado en 1995

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

artículo científico publicado en 2003

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

artículo científico publicado en 2016

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.

artículo científico publicado en 2019

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

artículo científico publicado en 2015

Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates

artículo científico publicado en 2010

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

artículo científico publicado en 2008

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus

artículo científico publicado en 2013

Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses

artículo científico publicado en 2008

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

artículo científico publicado en 2017